NCT05129280 2023-08-04
A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-tumor Activity of RO7444973 in Participants With Unresectable and/or Metastatic MAGE-A4-positive Solid Tumors
Hoffmann-La Roche
Phase 1 Terminated
Hoffmann-La Roche
Hoffmann-La Roche